CopyMark Law Group
4.9/5
Drawing for HEALTHFORCE

USPTO serial 87586898

HEALTHFORCE

Reviewed by CopyMark Law Group

Reg. 5437149Status 702Registered
Filing date
Status date
Registration date
Apr 3, 2018
Examiner
MAKHDOOM, SAIMA
Law office
Historical data usage

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with HEALTHFORCE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Joshua M. Gerben, Esq.

Joshua M. Gerben, Esq. Gerben Perrott, PLLC1050 Connecticut Ave NW, Suite 500Washington, DC 20036United States

Goods and services

ClassDescriptionStatusFirst use
005Nutritional SupplementsACTIVEJan 1, 1994

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 12, 2024NURCNOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED—
Oct 15, 2024NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Oct 15, 2024C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Oct 7, 2024C.7CNEW CERTIFICATE UNDER SECTION 7 - PROCESSED—
Oct 7, 2024APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jun 28, 2024ES7RTEAS SECTION 7 REQUEST RECEIVED—
Apr 8, 2024E815TEAS SECTION 8 & 15 RECEIVED—
Mar 13, 2024ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Dec 14, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 14, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Dec 14, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Apr 3, 2023REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jan 23, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jan 23, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 23, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 23, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 23, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Apr 3, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 16, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 16, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 27, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 5, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 1, 2017DOCKASSIGNED TO EXAMINER—
Sep 2, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 31, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance